IAVI

Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Scientific Publications

Development of a duplex real time RT qPCR assay to monitor genome replication gene expression and gene insert stability during in vivo replication of a prototype live attenuated canine distemper virus vector encoding SIV gag

Read more

Press Releases

IAVI Welcomes Promising Study

February 24, 2015

IAVI welcomes the promising results that Michael Farzan and his team have achieved by constructing an artificial protein that potently blocked HIV and SIV in vitro and protected against SHIV challenge in monkeys. These findings complement other ongoing studies aimed at designing prevention approaches that can work across the enormous diversity of HIV, and further…

Read more

Press Releases

Fast-replicating HIV Strains Drive Inflammation and Disease Progression

February 17, 2015

New findings inform prevention, treatment and cure research and development.

Read more

Press Releases

IAVI Receives GSK Funding for the Human Vaccines Project to Accelerate Development of Vaccines for Infectious Diseases and Cancer

February 13, 2015

NEW YORK – The International AIDS Vaccine Initiative (IAVI) has received a grant of US$350,000 from GSK to support implementation of the Human Vaccines Project, a new public-private partnership seeking to transform global disease prevention by collaboratively addressing some of the key scientific challenges in vaccine development across diseases. The GSK grant will help to establish…

Read more

Scientific Publications

Creating an African HIV clinical research and prevention trials network HIV prevalence incidence and transmission

Read more

Scientific Publications

Two classes of broadly neutralizing antibodies within a single lineage directed to the high mannose patch of HIV envelope

Read more

Press Releases

GSK Global Vaccines Chairman Moncef Slaoui Joins IAVI Board of Directors

January 8, 2015

The International AIDS Vaccine Initiative (IAVI) is pleased to announce that Dr. Moncef Slaoui, Chairman, Vaccines, GSK, has joined its Board of Directors. “Moncef Slaoui brings a wealth of experience in translating promising research into practical vaccines for use throughout the world,” said IAVI President and CEO Margie McGlynn. “His counsel will be crucial to…

Read more

Scientific Publications

Well ordered trimeric HIV 1 subtype B and C soluble spike mimetics generated by negative selection display native like properties

Read more